6 Things to Know About the Diagnosis 9 in 10 Americans Are About to Get

Here’s a health condition you’ve probably never heard of. Yet there’s nearly a 90% chance you already have some form of it.

It’s called cardiovascular-kidney-metabolic syndrome, or CKM for short. And as of last month, it’s not a fuzzy medical idea anymore. It’s official.

On June 9, four of the biggest names in medicine — the American Heart Association, the American College of Cardiology, and the national diabetes and kidney groups — released the first-ever guideline for spotting and treating it.

Translation? Next time you’re sitting on that crinkly paper at the doctor’s office, you might walk out with a brand-new label on your chart — one that comes with a stage number, some tests you’ve never had, and maybe a prescription.

So let’s talk about what this thing is, why you almost certainly have a piece of it, and what to do before your doctor brings it up.

1. It’s real now — and it comes with official rules

CKM syndrome ties together three things doctors used to treat in separate boxes: your heart, your kidneys, and your metabolism — the system that handles weight and blood sugar.

The big idea is that these systems feed each other. Trouble in one quietly drags down the others. “Heart, kidney, and metabolic conditions don’t occur in isolation,” said Dr. Chiadi Ndumele, who chaired the new guideline.

The term itself is young — the American Heart Association coined it in 2023. But the June guideline is what turns a concept into standard practice. It even retires the 2013 obesity guideline doctors had leaned on for more than a decade.

2. There’s a 9-in-10 chance this includes you

Nearly 90% of U.S. adults have at least one CKM risk factor: high blood pressure, off-kilter cholesterol, high blood sugar, extra weight, or reduced kidney function.

That same survey found something wild. Roughly 9 in 10 people had never heard of CKM at all. We’re talking about a condition that describes almost everybody and is known by almost nobody.

Now, one important catch. Having a single risk factor doesn’t mean you’re sick or headed for a heart attack. The 90% number is that broad because CKM is a continuum — it captures people who feel perfectly fine right alongside people with serious disease.

3. You’ll get a stage number, from 0 to 4

This is the part that’ll feel new. Under the guideline, you don’t just “have it” or not. You get staged.

1. Stage 0: No risk factors. You’re in the clear.
2. Stage 1: Extra or dysfunctional fat tissue — think a bigger waistline or early blood-sugar trouble.
3. Stage 2: Metabolic risk factors pile on — high blood pressure, high triglycerides, diabetes, or kidney disease.
4. Stage 3: Silent, early heart or blood-vessel disease you can’t feel yet.
5. Stage 4: Actual cardiovascular disease — a heart attack or stroke, with or without kidney failure.

Why bother numbering it? Because the whole point is to catch people at Stage 1 or 2 and stop the slide before they ever reach Stage 4.

Quick aside — most internet financial advice comes from people who weren’t alive during the last recession. I’ve been writing about money for more than 35 years. Want rock-solid advice? Sign up for the free Money Talks Newsletter. Takes 10 seconds. No fluff. No spam.

4. Your next checkup may include tests you’ve never had

The guideline tells doctors to screen more aggressively — so expect some new items on the lab slip.

Two of them check your kidneys: a blood test called eGFR that measures how well they filter, and a urine test called UACR that looks for protein leaking through. Together they catch kidney trouble long before you’d feel it.

There’s also a new risk calculator called PREVENT. It estimates your odds of heart disease over the next 10 and 30 years, and it folds in kidney and metabolic health — not just cholesterol.

One more twist: Doctors are now told to ask whether you can afford food or have stable housing. Money stress, it turns out, is a health risk factor too.

5. The drugs just got a green light

Here’s where it gets interesting. For the first time, the guideline recommends GLP-1 medications — the Ozempic and Wegovy family — for certain people with obesity or Type 2 diabetes plus other risk factors. It also leans on a class of kidney-and-heart-protecting drugs called SGLT2 inhibitors.

That’s a real shift. It moves these medications from “diabetes drugs” to “protect your heart and kidneys” drugs, which opens the door to a lot more prescriptions.

6. Here’s what to do before your doctor brings it up

Don’t wait to be told. Know your numbers — blood pressure, cholesterol, and blood sugar — and ask for those two kidney tests if you’ve never had them.

Then ask the question that matters: “What stage would I land in, and what’s the one change that would help most?” That turns a scary label into a to-do list.

And here’s the good news buried in all this. For most people caught early, CKM is reversible with the boring, unglamorous stuff — moving more, eating better, dropping a few pounds, getting blood pressure under control.

The frightening name is really just medicine finally admitting your heart, kidneys, and metabolism are on the same team. Caught early, most of this can be turned around. So don’t wait for the label at your next visit — start asking now.